Joel M. Kremer

Genetics of rheumatoid arthritis contributes to biology and drug discovery

P. Visscher, A. Zhernakova, Y. Kamatani, 2013, Nature.

Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study

J. Kremer, D. Furst, T. Dervieux, 2005, Annals of the rheumatic diseases.

Long-term exposure to methotrexate induces immunophenotypic changes, decreased methotrexate uptake and increased dihydrofolate gene copy number in Jurkat T cells.

J. Kremer, D. Lawrence, M. J. Hall, 1998, International journal of immunopharmacology.